Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reflect a robust exchange of insights about the publication, with participants highlighting specific research findings like the persistence of SARS-CoV-2 in gut biopsies even months post-infection. Phrases such as 'hinting at viral persistence' and references to the evolving memory B cell response demonstrate how the tone is both analytical and concerned about the long-term implications for immunity. The overall enthusiasm, captured in comments around the paper being 'fascinating' or a 'game changer,' accentuates the perceived importance of the research.
Most discussions support the findings of the publication, highlighting the evolving immune response to SARS-CoV-2.
There is a strong interest in the implications of the research, especially regarding the persistence of the virus and immune response.
Discussions delve deeply into the specifics of the study, referencing particular findings and their implications for long COVID and vaccine effectiveness.
Participants believe the findings have significant ramifications for understanding COVID-19 immunity and management.
Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the International Society for Vaccines! What a nice surprise and acknowledgment of the fantastic work by everyone involved and all 42 (!) authors!
B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server Nov 2020.
@WashburneAlex @gadboit @CBoy287 @CovidNewsNL @SolidEvidence @PeacockFlu As someone who studies SARS-CoV-2 evolution and immune escape, this is a naive question. Evolving selection pressure and epistasis: https://t.co/6iZNuuueC2 https://t.co/dIbHRkzTTv https://t.co/YzEKo51crv https://t.co/ugl5RT051G https://t.co/fkOmnAbWBM
bre de 2020), que tomando muestras de tejido intestinal, el virus podía permanecer mínimo 3 meses en 7 de las 14 personas estudiadas (el 50%). Éstas eran ASINTOMÁTICAS y tenían una PCR en nasofaringe negativa. -El virus se encontraba SOBRETODO en íleon, https://t.co/qkRYqRur80 https://t.co/Km1XNXKsxQ
"Other anatomopathological and immunological studies in adults have also shown that SARS-CoV-2 RNA and antigens can persist in the lung and extra-pulmonary areas... https://t.co/NSIs2xPKfP https://t.co/gnh1dvBOmO ...even in immunocompetent adults" https://t.co/PdOMmRw513 16/x
SARS-2 viral persistence has been described before in the gut. https://t.co/vQMOZwdP8g https://t.co/FuvfkaEPko https://t.co/aDLZ959VWz And found to be functionally important for the immune system 6 months after infection. 2/3 https://t.co/EYMNnGc0qR
This week we explore SARS-CoV-2's potential to infect intestinal cells, specifically enterocytes, revealing important aspects of viral replication and immune response. Recent studies indicate that enterocytes express…
This week we will analyze the impact of SARS-CoV-2 spike proteins on the alternative complement pathway. The discussion includes evidence that inhibiting factor D could mitigate complications in COVID-19, highlighting a…
This video discusses antibody immunity evolution to SARS-CoV-2. Scientific weekly reports analyze antibody level decline post-infection while memory B cells remain stable. Key findings highlight changes in clonal…
On this day in COVID history, January 18, 2021: Evolution of antibody immunity to SARS-CoV-2 - Nature Source: Nature #COVID #OnThisDay https://t.co/nVKKI1TTqN
On this day in COVID history, January 18, 2021: Evolution of antibody immunity to SARS-CoV-2 - Nature Source: Nature https://www.nature.com/articles/s41586-021-03207-w
@LateStagePlanet @limits_stop VP in 50% of intestinal biopsies https://t.co/xXuPuYg1cG https://t.co/JfVeHmqM1x
RT @dlingenfelter: SARS-CoV-2 persists in your gut and stimulates your immune system long after your infection. Results: - signs of live v…
RT @dlingenfelter: SARS-CoV-2 persists in your gut and stimulates your immune system long after your infection. Results: - signs of live v…
RT @inkblue01: Evolution of antibody immunity to SARS-CoV-2 https://t.co/BBAYT1V1uF Chronic fatigue syndrome is associated with chronic ent…
RT @inkblue01: Evolution of antibody immunity to SARS-CoV-2 https://t.co/BBAYT1V1uF Chronic fatigue syndrome is associated with chronic ent…
RT @inkblue01: Evolution of antibody immunity to SARS-CoV-2 https://t.co/BBAYT1V1uF Chronic fatigue syndrome is associated with chronic ent…
@microbeminded2 Evolution of antibody immunity to SARS-CoV-2 https://t.co/38HTLC10ed… Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach https://t.co/hDzmHGvfBe
RT @inkblue01: Evolution of antibody immunity to SARS-CoV-2 https://t.co/BBAYT1V1uF Chronic fatigue syndrome is associated with chronic ent…
Evolution of antibody immunity to SARS-CoV-2 https://t.co/BBAYT1V1uF Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach https://t.co/82pWL6IPd9
Evolution of Antibody Immunity to SARS-CoV-2 https://t.co/lOHvJcHPxH
RT @dlingenfelter: SARS-CoV-2 persists in your gut and stimulates your immune system long after your infection. Results: - signs of live v…
RT @inkblue01: Evolution of antibody immunity to SARS-CoV-2 https://t.co/HlWFOCvAhG
RT @inkblue01: Evolution of antibody immunity to SARS-CoV-2 https://t.co/HlWFOCvAhG
Evolution of Antibody Immunity to SARS-CoV-2 | bioRxiv https://t.co/IAuayZlEwo
RT @inkblue01: Evolution of antibody immunity to SARS-CoV-2 https://t.co/HlWFOCvAhG
Evolution of antibody immunity to SARS-CoV-2 https://t.co/HlWFOCvAhG
SARS-CoV-2 persists in your gut and stimulates your immune system long after your infection. Results: - signs of live virus 4 months after infection - more humoral response evolution - higher Ab potency - lower Ab titres - lower Ab neutralizing activity https://t.co/7U9uTjFCcn
@dlingenfelter Thanks for confirming. Virus persistence in gut biopsies was shown before. https://t.co/mru0kGyAOP and quoted for the mechanism of long covid. https://t.co/yjy4NFP80f
RT @0bj3ctivity: "Other anatomopathological and immunological studies in adults have also shown that SARS-CoV-2 RNA and antigens can persis…
RT @0bj3ctivity: "Other anatomopathological and immunological studies in adults have also shown that SARS-CoV-2 RNA and antigens can persis…
RT @0bj3ctivity: "Other anatomopathological and immunological studies in adults have also shown that SARS-CoV-2 RNA and antigens can persis…
RT @0bj3ctivity: "Other anatomopathological and immunological studies in adults have also shown that SARS-CoV-2 RNA and antigens can persis…
"Other anatomopathological and immunological studies in adults have also shown that SARS-CoV-2 RNA and antigens can persist in the lung and extra-pulmonary areas... https://t.co/NSIs2xPKfP https://t.co/gnh1dvBOmO ...even in immunocompetent adults" https://t.co/PdOMmRw513 16/x
Evolution of antibody immunity to SARS-CoV-2 https://t.co/BBAYT1V1uF
RT @inkblue01: Evolution of Antibody Immunity to SARS-CoV-2 Preprint Nov 2020 https://t.co/ef5RH6lRk7
RT @inkblue01: Evolution of Antibody Immunity to SARS-CoV-2 Preprint Nov 2020 https://t.co/ef5RH6lRk7
Evolution of Antibody Immunity to SARS-CoV-2 Preprint Nov 2020 https://t.co/ef5RH6lRk7
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
“Evolution of antibody immunity to SARS-CoV-2” https://t.co/BBAYT1V1uF
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
RT @inkblue01: B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server…
B cell memory continues to evolve 6 months after infection, hinting at viral persistence. This paper hit the preprint server Nov 2020.
Hier zur Studie, die schon vom Januar 2021 ist. Es ist also so, dass man alle #LC Patient*innen seit nunmehr fast 3 Jahren auf eine Virus-Persistenz im Darm hätte untersuchen können/sollen/müssen. https://t.co/3FmTGNqDIG Hier zu einer neueren Fassung: https://t.co/Ig9ttrpJFL
RT @NACREspirale: #COVIDー19 #covidlong De la notion d 'organes réservoirs de la covid pendant des mois. A la question cruciale de la vacc…
Evolution of antibody immunity to SARS-CoV-2 https://t.co/OdEgMa0JNS
Evolution of antibody immunity to SARS-CoV-2; memory B cell response to SARS-CoV-2 evolves between 1.3 and 6.2 months after infection in a manner that is consistent with antigen persistence. https://t.co/KM8ussMfSA
Evolution of antibody immunity to SARS-CoV-2 www.nature.com/articles/s41...
Evolution of antibody immunity to SARS-CoV-2 https://t.co/xSY2SQTq2q
7/1 Die Studie ergänzt zahlreiche andere, die Hinweise auf eine anhaltende Infektion Monate nach der akuten Erkrankung gefunden haben: https://t.co/AN3GFvZmSg https://t.co/83VyV39Kiw https://t.co/FQg9r2VOxI https://t.co/PG5PxzOus0 https://t.co/KBhXuWEYa2 https://t.co/bTd5xrGRvy
@THAILANDMEDICA1 We have been doing the same even here they're calling us mad
@Bogdan53067021 @OnlineDanas Naravno, vakcine nisu čarobni napitak sa svemogućom zaštitom već su kao pancir, možete biti ranjeni, ozleđeni ali spašavaju život, ako naleti protivpancirski metak-neće 1. https://t.co/u0sTmUTcEn 2. https://t.co/weylacKpUq 3. https://t.co/sffi4Lx4At 4. https://t.co/9Nkev7z0cH
RT @PaulBieniasz: @WashburneAlex @gadboit @CBoy287 @CovidNewsNL @SolidEvidence @PeacockFlu As someone who studies SARS-CoV-2 evolution and…
RT @PaulBieniasz: @WashburneAlex @gadboit @CBoy287 @CovidNewsNL @SolidEvidence @PeacockFlu As someone who studies SARS-CoV-2 evolution and…
@WashburneAlex @gadboit @CBoy287 @CovidNewsNL @SolidEvidence @PeacockFlu As someone who studies SARS-CoV-2 evolution and immune escape, this is a naive question. Evolving selection pressure and epistasis: https://t.co/6iZNuuueC2 https://t.co/dIbHRkzTTv https://t.co/YzEKo51crv https://t.co/ugl5RT051G https://t.co/fkOmnAbWBM
RT @johnjljacobs: SARS-2 viral persistence has been described before in the gut. https://t.co/vQMOZwdP8g https://t.co/FuvfkaEPko https://t.…
RT @johnjljacobs: SARS-2 viral persistence has been described before in the gut. https://t.co/vQMOZwdP8g https://t.co/FuvfkaEPko https://t.…
RT @johnjljacobs: SARS-2 viral persistence has been described before in the gut. https://t.co/vQMOZwdP8g https://t.co/FuvfkaEPko https://t.…
RT @johnjljacobs: SARS-2 viral persistence has been described before in the gut. https://t.co/vQMOZwdP8g https://t.co/FuvfkaEPko https://t.…
SARS-2 viral persistence has been described before in the gut. https://t.co/vQMOZwdP8g https://t.co/FuvfkaEPko https://t.co/aDLZ959VWz And found to be functionally important for the immune system 6 months after infection. 2/3 https://t.co/EYMNnGc0qR
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @midorinoaojiru: （39:30～） ACE2を一番多く発現しているのは、小腸。（井上先生） 論文でも、発症の4ヵ月後に小腸からウイルスDNAが検出されたと書かれていた。 「腸生検の免疫蛍光およびPCR分析により、14人中7人の小腸におけるSARS-Co…
（39:30～） ACE2を一番多く発現しているのは、小腸。（井上先生） 論文でも、発症の4ヵ月後に小腸からウイルスDNAが検出されたと書かれていた。 「腸生検の免疫蛍光およびPCR分析により、14人中7人の小腸におけるSARS-CoV-2核酸の持続性と免疫反応性が明らかになった」 https://t.co/IdjmVkfiWm https://t.co/2cLnPvRY9S
RT @mir_albert: bre de 2020), que tomando muestras de tejido intestinal, el virus podía permanecer mínimo 3 meses en 7 de las 14 personas…
@AlexxSeas I am 50/50 on this as well. Before I’d have said just fragments but after seeing this (nucleocapsid) https://t.co/vIylZtC9TG I really don’t know I’m leaning more to live virus destroyed daily & that’s why we see fragments.
#SARSCoV2_pathology #Bcells #antibodies #memory_B_cells #IgA #IgM #IgG #immunoflourescence “Evolution of antibody immunity to SARS-CoV-2” 1/18/2021 “…continued evolution of humoral response” https://t.co/MUutMzGs49 https://t.co/IW0ibMmbbz
RT @mir_albert: bre de 2020), que tomando muestras de tejido intestinal, el virus podía permanecer mínimo 3 meses en 7 de las 14 personas…
RT @mir_albert: bre de 2020), que tomando muestras de tejido intestinal, el virus podía permanecer mínimo 3 meses en 7 de las 14 personas…
bre de 2020), que tomando muestras de tejido intestinal, el virus podía permanecer mínimo 3 meses en 7 de las 14 personas estudiadas (el 50%). Éstas eran ASINTOMÁTICAS y tenían una PCR en nasofaringe negativa. -El virus se encontraba SOBRETODO en íleon, https://t.co/qkRYqRur80 https://t.co/Km1XNXKsxQ
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
https://t.co/WVo03ACdGf
てか、 ワクチン接種後早期は、 ある程度、鍵のバリエーションは持てているのだが、時間が経つとバリエーションが少なくなっちゃうのよね。 これを維持するためのブースターとしていいのかと。 https://t.co/SjpmRn6U7r
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
RT @c_gaebler: Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the Internationa…
Our paper "Evolution of antibody immunity to SARS-CoV-2" has been selected as the 2021 Paper of the Year by the International Society for Vaccines! What a nice surprise and acknowledgment of the fantastic work by everyone involved and all 42 (!) authors!
RT @HLFrisbie: Referencias Gaebler, C., Wang, Z., Lorenzi, J.C.C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639–644…
Referencias Gaebler, C., Wang, Z., Lorenzi, J.C.C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639–644 (2021). https://t.co/VYvR2A3wjX Lamers, M. M. et al. SARS-CoV-2 productively infects human gut enterocytes. Science 369, 50–54 (2020)
intestinal biopsies obtained from asymptomatic individuals at 4 months after the onset of coronavirus disease 2019 (COVID-19) revealed the persistence of SARS-CoV-2 nucleic acids and immunoreactivity in the small bowel of 7 out of 14 individuals. https://t.co/uvh0PXBbue
2/ memory B cell matured Abs better at fighting virus variation. This is unlikely to occur with vaccines which have a short half life in vivo but the improved immunity from natural infection a dangerous risk:reward calculation. #vaccinessavelives https://t.co/CV8zKZ1QuL
@DIVIZIO1 Nature. 2021 Mar;591(7851):639-644. doi: 10.1038/s41586-021-03207-w. Epub 2021 Jan 18. Evolution of antibody immunity to SARS-CoV-2 https://t.co/vwPLpVqMW5
RT @MeloWeller: Evolution of antibody immunity to SARS-CoV-2. Viral antigens and genome detected >90 days post #COVID19 symptom onset. Vir…
Evolution of antibody immunity to SARS-CoV-2 | Nature, 18 January 2021 https://t.co/I3LOtr1p4m
@gerdosi @azra_wi @caru_fred @catherinefonck thank you, really intersting links ... one half of people are immunocompromised (cf Rockfeller 11/20) ? il like the concept of dysimmunity as used by Prof. Salmon, immune system work but not entirely https://t.co/yJ3cCKIT0z
Evolution of antibody immunity to SARS-CoV-2. Viral antigens and genome detected >90 days post #COVID19 symptom onset. Viral Reservoir Tissue: GI https://t.co/0QiFbosxi8
@mariaitapia @RaquelDiazMart6 https://t.co/qkRYqRM1Zy https://t.co/jJS20zrXVB Este último aún no lo han publicado pero es de los mismos autores: https://t.co/tePgYU9e9J
@brlarl @drkaracenk https://t.co/siGnZtASAz Altında da benzer bir sürü makale var
Part 21. Evolution of antibodies. #ncpol #lawsofnature BCells don't decay after 6 Months but continue to evolve Evolution of antibody immunity to SARS-CoV-2 https://t.co/o1K1ltIvdo https://t.co/9RDre6zRmX
Evolution of antibody immunity to SARS-CoV-2 | Nature https://t.co/D83JI3aS2p
@gloriasantiagoc @Dr_Pilgrim Podría ser esto. 2/2 https://t.co/qkRYqRur80 https://t.co/w0fKtLH6hG
RT @mir_albert: @JohannHolzmann @VirusesImmunity In the document on my wall are explained. https://t.co/qkRYqRur80 https://t.co/jJS20zan43…
@JohannHolzmann @VirusesImmunity In the document on my wall are explained. https://t.co/qkRYqRur80 https://t.co/jJS20zan43 https://t.co/JJyW8B9MHi
A new "Article in the Spotlight" post is now up on the Levy Library blog! This month we spotlight "Evolution of antibody immunity to SARS-CoV-2." To date, this article has been cited 107 times and received 674 social media interactions. Read it here: https://t.co/mCuyjh4CDC https://t.co/5Sf1VHsWzp
@VincentRK Welcome to Homocysteine induced neuronal apoptosis by a mainly ileal virus (SARS-CoV2) that can cause B12 malabsorption in the intestinal level and severe 1-C metabolites consumption. https://t.co/qkRYqRur80 https://t.co/Vhk6VBg1HS
meses después y en asintomáticos con una PCR en NF negativa. https://t.co/c0jfyQBjef https://t.co/lzQBL49ER5 https://t.co/qkRYqRur80 https://t.co/jJS20zan43 https://t.co/H9NPRWKNpR 5/8
@invest_trades @benito_inma @Macarena_Olona Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature [Internet]. marzo de 2021 [citado 30 de abril de 2021];591(7851):639-44. Disponible en: https://t.co/z3Ncdnwxo4 ⬇️
@Dr_Pilgrim @nikomer75 @mariagallegobl @CinPek Estoy de acuerdo. Pero parece que en estos estudios se cumple. No puedo hacer más ya. Lo siguiente es subrayarte los documentos. https://t.co/c0jfyQBjef https://t.co/lzQBL49ER5 https://t.co/qkRYqRur80 https://t.co/jJS20zan43 https://t.co/H9NPRWKNpR
Evolution of Antibody Immunity to SARS-CoV-2 https://t.co/dfoaZxEwMF
@yellowman_a 一応Natureに論文があるのですが、200日以上IgGが確認されるね、それは長寿命のB細胞由来だから長く持つかもね、再感染から保護されるかもね、と言った程度の話です ＞Evolution of antibody immunity to SARS-CoV-2 | Nature https://t.co/6yvIGlwd2p
RT @profshanecrotty: https://t.co/n0qWRSVhjY
Viral persistency of virus RNA may play a role in evolution of antibody immunity against SARS-CoV-2. 5/8 https://t.co/EYMNnGc0qR
@BlasIgnacio lo más fiable, aunque costoso, son las biopsias de intestino delgado. https://t.co/Ith7ay6PTs https://t.co/c0jfyQBjef https://t.co/qkRYqRur80 Este último es reciente (muy completo) muestra que el virus inactiva la respuesta inflamatoria intestinal: https://t.co/jJS20zan43
@A_SisoAlmirall @CAMFiC Estudis intestinals: https://t.co/Ith7ay6PTs https://t.co/c0jfyQBjef https://t.co/qkRYqRur80 https://t.co/wbNmBbUccs Aquest és ben recent: https://t.co/jJS20zan43
Evolution of antibody immunity to #SARS_CoV_2 "The memory B cell response to SARS-CoV-2 evolves between 1.3 and 6.2 months after infection in a manner that is consistent with antigen persistence."
RT @guerreroespejo: Evolution of Antibody Immunity to SARS-CoV-2 Memory B cells display clonal turnover after 6.2 months, The memory B ce…
Evolution of Antibody Immunity to SARS-CoV-2 Memory B cells display clonal turnover after 6.2 months, The memory B cell response to SARS-CoV-2 evolves between 1.3 and 6.2 months after infection in a manner that is consistent with antigen persistence. https://t.co/qvPHmk53Ai
RT @profshanecrotty: https://t.co/n0qWRSVhjY
#GoodNews everyone Evolution of antibody immunity to SARS-CoV-2 https://t.co/lqkUdMatDD
RT @kenmomd: Nature ハイライト：SARS-CoV-2に対する記憶B細胞応答の6か月にわたる進化 | Nature | Nature Portfolio https://t.co/7aIsjt6CNd Evolution of antibody immuni…
RT @kenmomd: Nature ハイライト：SARS-CoV-2に対する記憶B細胞応答の6か月にわたる進化 | Nature | Nature Portfolio https://t.co/7aIsjt6CNd Evolution of antibody immuni…
RT @kenmomd: Nature ハイライト：SARS-CoV-2に対する記憶B細胞応答の6か月にわたる進化 | Nature | Nature Portfolio https://t.co/7aIsjt6CNd Evolution of antibody immuni…
Nature ハイライト：SARS-CoV-2に対する記憶B細胞応答の6か月にわたる進化 | Nature | Nature Portfolio https://t.co/7aIsjt6CNd Evolution of antibody immunity to SARS-CoV-2 Christian Gaebler et al. Published: 18 January 2021 https://t.co/eEAn2rq6GM
Evolution of antibody immunity to SARS-CoV-2 [Jan 18, 2021] @c_gaebler et al. @NussenzweigL @nature https://t.co/X6ODAGJONf #2019nCoV #COVID19
@NIHRresearch @MassCPR @Eric_Y_Wang @VirusesImmunity @aaronmring @profshanecrotty @c_gaebler @bjorkmanlab @PaulBieniasz @theodora_nyc 2021 - antibody evolution & GI persistence https://t.co/LDIxTn6l2j Dias De Melo 2020 - persistence in olfactory system https://t.co/3qTePp3qOP @FCrunfli 2021 - astrocyte infection https://t.co/rkD6Foh9uI
@MarionKoopmans @rivm The assay seems to play an important role in measuring the antibodies another recent paper concludes that IgA-RBD persist longer than IgG-RBD: Evolution of Antibody Immunity to SARS-CoV-2 https://t.co/7uce6qBMu1
The preprint “Evolution of Antibody Immunity to SARS-CoV-2” (https://t.co/vfCgne1qVV) has been reviewed by automated tools, find results here: https://t.co/RKujRdZ8V5. We detected 3 of 6 rigor criteria, 21 resources, open data, open code, and no limitations statement.
RT @profshanecrotty: https://t.co/n0qWRSVhjY
RT @profshanecrotty: https://t.co/n0qWRSVhjY
https://t.co/n0qWRSVhjY
@Anja_InnatOss @bassjobsen @maars199 @Saskia_Furdytje @hugodejonge @Gezondheidsraad 2. Er zijn 2 hypothesen over #LongCovid A - Auto-immuniteit. Dan wil je geen antistoffen. B - Persistente infectie. Dan worden antistoffen beter, maar beschermen niet. https://t.co/yjy4NFP80f https://t.co/mru0kGyAOP
Maybe waiting a little longer allows B cell hypermutation to evolve the antibody repertoire. I wonder if you’ll get better variant neutralization this way? Consider Gaebler et al 2021; Nature: https://t.co/yyT7pcnKcC @JenGommerman @florian_krammer https://t.co/yLwkO1NVP8
RT @RubiesRRed1: @drbeen_medical for you Sir. https://t.co/0yz68FFwzx and excellent study in Nature on the Evolution of antibody immunity…
@drbeen_medical for you Sir. https://t.co/0yz68FFwzx and excellent study in Nature on the Evolution of antibody immunity to SARS-CoV-2. It’s fascinating.
"We conclude that the memory B cell response to SARS-CoV-2 evolves between 1.3 and 6.2 months after infection in a manner that is consistent with antigen persistence." We have a short window to get #vaccination done and eliminate this virus from the UK. https://t.co/v7FigPjB5K https://t.co/mN1DN45mA1
B cells: fábricas de anticuerpos que meses después de covid han perfeccionado su técnica aunque los niveles de antic bajen en sangre. Más importantes que antic largo plazo> https://t.co/UYGTW6Od9u
RT @dronita_de: Evolution of antibody immunity to SARS-CoV-2 https://t.co/xnGzSrlCyF #DHPSP
RT @dronita_de: Evolution of antibody immunity to SARS-CoV-2 https://t.co/xnGzSrlCyF #DHPSP
RT @dronita_de: Evolution of antibody immunity to SARS-CoV-2 https://t.co/xnGzSrlCyF #DHPSP
RT @dronita_de: Evolution of antibody immunity to SARS-CoV-2 https://t.co/xnGzSrlCyF #DHPSP
RT @dronita_de: Evolution of antibody immunity to SARS-CoV-2 https://t.co/xnGzSrlCyF #DHPSP
RT @dronita_de: Evolution of antibody immunity to SARS-CoV-2 https://t.co/xnGzSrlCyF #DHPSP
RT @dronita_de: Evolution of antibody immunity to SARS-CoV-2 https://t.co/xnGzSrlCyF #DHPSP
RT @dronita_de: Evolution of antibody immunity to SARS-CoV-2 https://t.co/xnGzSrlCyF #DHPSP
Evolution of antibody immunity to SARS-CoV-2 https://t.co/z2UrfywPbX https://t.co/zURVwI2Dqe "the memory B cell response to SARS-CoV-2 evolves between 1.3 and 6.2 months after infection in a manner that is consistent with antigen persistence"
Evolution of antibody immunity to SARS-CoV-2 https://t.co/xnGzSrlCyF #DHPSP
RT @ARadlerPohlDr: .... und die Natur hat wieder die bessere Lösung!!! - die B-Gedächtniszellen bleiben nicht nur über 6 Monate - sie passe…
RT @ARadlerPohlDr: .... und die Natur hat wieder die bessere Lösung!!! - die B-Gedächtniszellen bleiben nicht nur über 6 Monate - sie passe…
.... und die Natur hat wieder die bessere Lösung!!! - die B-Gedächtniszellen bleiben nicht nur über 6 Monate - sie passen sich variabel an ihr Ziel an ... Genial - tolles Paper! https://t.co/8f6DPKUnYP
Trending on PubMed: Evolution of antibody immunity to SARS-CoV-2. https://t.co/qFqbiBtrjH
Key question in C-19 immunity: memory B cell response Gaebler, C., Wang, Z., Lorenzi, J.C.C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature (2021). https://t.co/23BKXRkS6f
RT @LarryBoorstein: Gaebler, C., Wang, Z., Lorenzi, J.C.C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature (2021). https://t.co…
RT @LarryBoorstein: Gaebler, C., Wang, Z., Lorenzi, J.C.C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature (2021). https://t.co…
Gaebler, C., Wang, Z., Lorenzi, J.C.C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature (2021). https://t.co/Lkm6cpoRR4
11 co-first authors
4/4 Gaebler, C., Wang, Z., Lorenzi, J.C.C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature (2021). https://t.co/cnvUSFxmZ9 [accelerated article preview]
N/ Evolution of antibody immunity to SARS-CoV-2. https://t.co/C19XaxP0iA
El #antígeno es retenido en la superficie de las #célulasDendríticas foliculares durante períodos prolongados y aumenta la eficiencia del proceso. Gaebler, C., Wang, Z., Lorenzi, J.C.C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature (2021). https://t.co/IRWMD6VAY1
@juliovschneider @vuejs Evolução da imunidade de anticorpos ao SARS-CoV-2 Christian Gaebler et al. Nature . 2021. https://t.co/iChD9FmJ0x